Trials / Completed
CompletedNCT01803126
A Proposed Study of Atherosclerotic Plaques in Leg Arteries
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Southwest Regional Wound Care Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Biofilm has been identified as the major bacterial phenotype contributing to atherosclerosis. It has become very important to evaluate atherosclerosis and the role of biofilm using advanced technologies. It is also important to understand wound biofilm at a genetic and a molecular level.
Detailed description
High throughput pyrosequencing is opening new doors in nucleic acid analysis. 454 Roche has developed sequencing instrumentation which has the ability to sequence not only genomic DNA (gDNA) but also derivatives of messenger RNA (mRNA) and 16s ribosomal DNA (rDNA). This technology has the potential to survey the nucleic acids involved within a mixed population of species, such as atherosclerotic biofilm. In addition to transcriptome science; proteome, metabolome, and other -omic sciences are advancing rapidly. Examining atherosclerotic plaque using transcriptome, proteome, metabolome, and other -omic approaches may provide valuable insight into the wound's microecology.
Conditions
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2013-03-04
- Last updated
- 2018-06-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01803126. Inclusion in this directory is not an endorsement.